Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
HLSHP's Cash to Debt is ranked lower than
58% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.14 vs. HLSHP: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
HLSHP' s 10-Year Cash to Debt Range
Min: 0.01   Max: N/A
Current: 0.09

Equity to Asset 0.14
HLSHP's Equity to Asset is ranked lower than
64% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. HLSHP: 0.14 )
Ranked among companies with meaningful Equity to Asset only.
HLSHP' s 10-Year Equity to Asset Range
Min: -0.77   Max: 0.59
Current: 0.14

-0.77
0.59
Interest Coverage 4.28
HLSHP's Interest Coverage is ranked higher than
70% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 4.28 )
Ranked among companies with meaningful Interest Coverage only.
HLSHP' s 10-Year Interest Coverage Range
Min: 0.29   Max: 9999.99
Current: 4.28

0.29
9999.99
F-Score: 4
Z-Score: 1.35
M-Score: -2.54
WACC vs ROIC
10.40%
16.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 18.72
HLSHP's Operating margin (%) is ranked higher than
89% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. HLSHP: 18.72 )
Ranked among companies with meaningful Operating margin (%) only.
HLSHP' s 10-Year Operating margin (%) Range
Min: -3.55   Max: 37.8
Current: 18.72

-3.55
37.8
Net-margin (%) 8.64
HLSHP's Net-margin (%) is ranked higher than
79% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. HLSHP: 8.64 )
Ranked among companies with meaningful Net-margin (%) only.
HLSHP' s 10-Year Net-margin (%) Range
Min: -36.52   Max: 48.3
Current: 8.64

-36.52
48.3
ROE (%) 49.85
HLSHP's ROE (%) is ranked higher than
98% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. HLSHP: 49.85 )
Ranked among companies with meaningful ROE (%) only.
HLSHP' s 10-Year ROE (%) Range
Min: -22.44   Max: 1312.58
Current: 49.85

-22.44
1312.58
ROA (%) 7.31
HLSHP's ROA (%) is ranked higher than
79% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. HLSHP: 7.31 )
Ranked among companies with meaningful ROA (%) only.
HLSHP' s 10-Year ROA (%) Range
Min: -17.98   Max: 44.36
Current: 7.31

-17.98
44.36
ROC (Joel Greenblatt) (%) 38.21
HLSHP's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 8.51 vs. HLSHP: 38.21 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HLSHP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -17.71   Max: 129.42
Current: 38.21

-17.71
129.42
Revenue Growth (3Y)(%) 8.70
HLSHP's Revenue Growth (3Y)(%) is ranked higher than
74% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: -12.00 vs. HLSHP: 8.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HLSHP' s 10-Year Revenue Growth (3Y)(%) Range
Min: -27   Max: 8.7
Current: 8.7

-27
8.7
EBITDA Growth (3Y)(%) 14.10
HLSHP's EBITDA Growth (3Y)(%) is ranked higher than
88% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 14.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HLSHP' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 19.8
Current: 14.1

0
19.8
EPS Growth (3Y)(%) 16.40
HLSHP's EPS Growth (3Y)(%) is ranked higher than
84% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 16.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HLSHP' s 10-Year EPS Growth (3Y)(%) Range
Min: -34.2   Max: 56
Current: 16.4

-34.2
56
» HLSHP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HLSHP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1557.374.206 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 19.80
HLSHP's P/E(ttm) is ranked higher than
83% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 19.80 )
Ranked among companies with meaningful P/E(ttm) only.
HLSHP' s 10-Year P/E(ttm) Range
Min: 1.71   Max: 32.2
Current: 19.8

1.71
32.2
Forward P/E 17.06
HLSHP's Forward P/E is ranked higher than
81% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 17.06 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 20.30
HLSHP's PE(NRI) is ranked higher than
83% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 247.00 vs. HLSHP: 20.30 )
Ranked among companies with meaningful PE(NRI) only.
HLSHP' s 10-Year PE(NRI) Range
Min: 1.84   Max: 181.64
Current: 20.3

1.84
181.64
P/B 7.86
HLSHP's P/B is ranked lower than
89% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. HLSHP: 7.86 )
Ranked among companies with meaningful P/B only.
HLSHP' s 10-Year P/B Range
Min: 6.91   Max: 191.71
Current: 7.86

6.91
191.71
P/S 1.75
HLSHP's P/S is ranked lower than
63% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. HLSHP: 1.75 )
Ranked among companies with meaningful P/S only.
HLSHP' s 10-Year P/S Range
Min: 0.4   Max: 3.95
Current: 1.75

0.4
3.95
PFCF 15.23
HLSHP's PFCF is ranked higher than
81% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 46.50 vs. HLSHP: 15.23 )
Ranked among companies with meaningful PFCF only.
HLSHP' s 10-Year PFCF Range
Min: 1.77   Max: 17.58
Current: 15.23

1.77
17.58
POCF 10.03
HLSHP's POCF is ranked higher than
80% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 35.89 vs. HLSHP: 10.03 )
Ranked among companies with meaningful POCF only.
HLSHP' s 10-Year POCF Range
Min: 1.53   Max: 10.7
Current: 10.03

1.53
10.7
EV-to-EBIT 13.20
HLSHP's EV-to-EBIT is ranked higher than
85% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 47.98 vs. HLSHP: 13.20 )
Ranked among companies with meaningful EV-to-EBIT only.
HLSHP' s 10-Year EV-to-EBIT Range
Min: -35.1   Max: 90.2
Current: 13.2

-35.1
90.2
PEG 1.34
HLSHP's PEG is ranked higher than
95% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 1.34 )
Ranked among companies with meaningful PEG only.
HLSHP' s 10-Year PEG Range
Min: 1.03   Max: 2.66
Current: 1.34

1.03
2.66
Shiller P/E 14.70
HLSHP's Shiller P/E is ranked higher than
95% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 14.70 )
Ranked among companies with meaningful Shiller P/E only.
HLSHP' s 10-Year Shiller P/E Range
Min: 5.19   Max: 41.57
Current: 14.7

5.19
41.57
Current Ratio 1.74
HLSHP's Current Ratio is ranked higher than
76% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.97 vs. HLSHP: 1.74 )
Ranked among companies with meaningful Current Ratio only.
HLSHP' s 10-Year Current Ratio Range
Min: 0.6   Max: 6.95
Current: 1.74

0.6
6.95
Quick Ratio 1.74
HLSHP's Quick Ratio is ranked higher than
80% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.87 vs. HLSHP: 1.74 )
Ranked among companies with meaningful Quick Ratio only.
HLSHP' s 10-Year Quick Ratio Range
Min: 0.6   Max: 6.95
Current: 1.74

0.6
6.95
Days Sales Outstanding 48.95
HLSHP's Days Sales Outstanding is ranked higher than
61% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 59.97 vs. HLSHP: 48.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLSHP' s 10-Year Days Sales Outstanding Range
Min: 40.54   Max: 89.44
Current: 48.95

40.54
89.44

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.19
HLSHP's Price/DCF (Projected) is ranked higher than
84% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 1.19 )
Ranked among companies with meaningful Price/DCF (Projected) only.
HLSHP' s 10-Year Price/DCF (Projected) Range
Min: 0.57   Max: 209.14
Current: 1.19

0.57
209.14
Price/Median PS Value 1.53
HLSHP's Price/Median PS Value is ranked lower than
67% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. HLSHP: 1.53 )
Ranked among companies with meaningful Price/Median PS Value only.
HLSHP' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 3.41
Current: 1.53

0.42
3.41
Price/Peter Lynch Fair Value 1.32
HLSHP's Price/Peter Lynch Fair Value is ranked higher than
93% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 1.32 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HLSHP' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.1   Max: 5.91
Current: 1.32

0.1
5.91
Earnings Yield (Greenblatt) 7.60
HLSHP's Earnings Yield (Greenblatt) is ranked higher than
87% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 3.20 vs. HLSHP: 7.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
HLSHP' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 16.5
Current: 7.6

1.1
16.5
Forward Rate of Return (Yacktman) 20.78
HLSHP's Forward Rate of Return (Yacktman) is ranked higher than
92% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLSHP: 20.78 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
HLSHP' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.2   Max: 26.7
Current: 20.78

3.2
26.7

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:HLS.USA, HSOA.Germany,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK